FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2020/12/030089 [Registered on: 29/12/2020] Trial Registered Prospectively
Last Modified On: 28/12/2020
Post Graduate Thesis  No 
Type of Trial  Observational 
Type of Study   Case series study 
Study Design  Other 
Public Title of Study   C-reactive protein and Red cell distribution width in the assessment of severity and out come of organophosphorus poisoning 
Scientific Title of Study   C-reactive protein and Red cell distribution width as a prognostic marker for outcome of Organophosphorus poisoning  
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  DRGSREENATH 
Designation  junior resident 
Affiliation  S.Nijalingappa medical college and Hangal shri kumareshwara hospital 
Address  Department of General Medicine, S.Nijalingappa Medical college and Hangal shri kumareshwara hospital,navanagar,Bagalkot, Karnataka,India.

Bagalkot
KARNATAKA
587102
India 
Phone  9611264888  
Fax    
Email  sreenath344@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  DRKRUTIKA MORAPPANAVAR 
Designation  ASSISTANT PROFESSOR 
Affiliation  S.Nijalingappa medical college and Hangal shri kumareshwara hospital 
Address  Department of General Medicine, S.Nijalingappa medical college and Hangal shri kumareshwara hospital,navanagar,Bagalkot, Karnataka,India.

Bagalkot
KARNATAKA
587102
India 
Phone  9164504415  
Fax    
Email  drkrutika14488@gmail.com  
 
Details of Contact Person
Public Query
 
Name  DR KRUTIKA MORAPPANAVAR 
Designation  ASSISTANT PROFESSOR 
Affiliation  S.Nijalingappa medical college and Hangal shri kumareshwara hospital 
Address  Department of General Medicine ,S.Nijalingappa medical college and Hangal shri kumareshwara hospital,navanagar,Bagalkot, Karnataka,India.

Bagalkot
KARNATAKA
587102
India 
Phone  9164504415  
Fax    
Email  drkrutika14488@gmail.com  
 
Source of Monetary or Material Support  
S.Nijalingappa medical college and Hangal shri kumareshwara hospital,navanagar,Bagalkot, Karnataka,India. 
 
Primary Sponsor  
Name  SNMC HSK HOSPITAL BAGALKOT 
Address  S.Nijalingappa medical college and Hangal shri kumareshwara hospital,navanagar,Bagalkot, Karnataka,India. Bagalkot KARNATAKA 587102 India 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DRGSreenath  S.Nijalingappa medical college and Hangal shri kumareshwara hospital  Department of general medicine.
Bagalkot
KARNATAKA 
9611264888

sreenath344@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
instituional ethical comite  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: O||Medical and Surgical,  
 
Intervention / Comparator Agent  
Type  Name  Details 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  90.00 Year(s)
Gender  Both 
Details  All patients aged more than 18 years who are admitted with acute organophosphorus poisoning within 24 hours with clinical features and physical evidence of consumption of the poison. 
 
ExclusionCriteria 
Details  1. Patients less than 18 years.
2. Co-ingestion of organophosphorus compounds with other agents.
3. Patient with autoimmune diseases.
4. Prior history of Iron deficiency anemia, Vitamin B12 deficiency and folate deficiency anemia.
5. Recent hemorrhage.
6. Chronic liver disease.
7. Prior chemotherapy.
8. Patient on oral contraceptive pills.
9. Patient on estrogen therapy.
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
;RDW and CRP
Can be used as a prognostic marker in the assessment of severity of OP compound poisoning .Thus help in anticipating complications and addressing them appropriately.

 
on the day of admission and 48 hours after admission
 
 
Secondary Outcome  
Outcome  TimePoints 
RDW and CRP
Can be used as a prognostic marker in the assessment of severity of OP compound poisoning .Thus help in anticipating complications and addressing them appropriately.
 
on the day of admission and 48 hours after admission
 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   31/12/2020 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   NIL 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary    organophosphate (OP) compounds are frequently used as pesticides in countries like ours ,where a great deal of agricultural activities are involved.The ease of availability of the OP compounds has resulted in a gradual increase in unintentional and suicidal poisoning,mainly in developing countries.The world health organization (WHO) has estimated that more than 300 million acute pesticide poisoning occur worldwide each year and most of these cases are due to OP intoxication.The mortality rate of acute OP poisoning is 10%-20% and WHO has estimated that 2,00000 people die each year from pesticide poisoning.Elevated Red cell distribution Width is found in systemic inflammation and oxidative stress.The exact underlying mechanism is not well understood .Oxidative stress is defined as disturbance of the balance between the production of free radicals and the antioxidant capacity of the body.More severe the poisoning more is the production of free radicals and more oxidative stress.Increased oxidative stress contributes to an increase in lipid per oxidation and decrease in the phospholipids content of the erythrocyte membrane.As a result the erythrocyte membrane is damaged and erythrocytes lose their integrity.The lifespan of mature erythrocytes is shortened.In OP poisoning ,there is acute inflammation and increased oxidative stress that can lead to a change in the structure and size of the circulating erythrocyte .Hence it is expected that RDW levels may be increased in OP poisoning and thus can aid in prognosis.CRP is an acute phase reactant that can be used for monitoring of infection or autoimmune disease.In patients with such diseases,cytokine,mainly interleukin-6,stimulates the liver cells and promotes the productions of CRP.In acute OP Poisoning,toxins may cause lesions in tissues and organs in the body, leading to increased plasma CRP levels.We intend to evaluate  utility  of these two routinely available and inexpensive tests in prognostication of OP poisoning.  
 
Close